| Year |
Citation |
Score |
| 2021 |
Srisakuldee W, Nickel BE, Fandrich RR, Zhang F, Pasumarthi KBS, Kardami E. A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition. Cells. 10. PMID 34685716 DOI: 10.3390/cells10102735 |
0.306 |
|
| 2021 |
Landry NM, Rattan SG, Filomeno KL, Meier TW, Meier SC, Foran SJ, Meier CF, Koleini N, Fandrich RR, Kardami E, Duhamel TA, Dixon IMC. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation. Basic Research in Cardiology. 116: 25. PMID 33847835 DOI: 10.1007/s00395-021-00865-9 |
0.351 |
|
| 2020 |
Kardami E, Koleini N, Nickel B, Nagalingam R, Landry NM, Fandrich RR, Cheung DY, Dixon IM, Czubryt MP, Jassal DS, Cattini PA. Changes in gene expression caused by genetic elimination of high molecular weight FGF2 are associated with prevention of stress‐induced cardiac systolic dysfunction The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06047 |
0.334 |
|
| 2019 |
Chen X, Li Z, Cheng Y, Kardami E, Loh YP. Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity. Frontiers in Molecular Neuroscience. 12: 328. PMID 32038161 DOI: 10.3389/Fnmol.2019.00328 |
0.398 |
|
| 2019 |
Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y, Marzban H, Xu F, Thliveris J, Kardami E, Hatch GM, et al. Simvastatin Increases Temozolomide-induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes. The Febs Journal. PMID 31545550 DOI: 10.1111/Febs.15069 |
0.304 |
|
| 2019 |
Koleini N, Nickel BE, Edel AL, Fandrich RR, Ravandi A, Kardami E. Oxidized phospholipids in Doxorubicin-induced cardiotoxicity. Chemico-Biological Interactions. PMID 30707978 DOI: 10.1016/J.Cbi.2019.01.032 |
0.311 |
|
| 2019 |
Hlavackova M, Kardami E, Fandrich R, Pierce GN. Do different nuclei in a binucleated cardiomyocyte have different rates of nuclear protein import? Journal of Molecular and Cellular Cardiology. 126: 140-142. PMID 30502349 DOI: 10.1016/J.Yjmcc.2018.08.030 |
0.346 |
|
| 2019 |
Koleini N, Nickel BE, Nagalingam RS, Landry NM, Fandrich RR, Dixon IM, Czubryt M, Cattini PA, Kardami E. Abstract 838: High Molecular Weight FGF2 Contributes to Pressure Overload Induced Systolic Dysfunction by a Mechanism Associated With Modulation of the NR1D1 Orphan Nuclear Receptor Expression Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.838 |
0.302 |
|
| 2018 |
Koleini N, Santiago JJ, Nickel BE, Sequiera GL, Wang J, Fandrich RR, Jassal DS, Dhingra S, Kirshenbaum LA, Cattini PA, Kardami E. Elimination or neutralization of endogenous high molecular weight FGF2 mitigates Doxorubicin induced cardiotoxicity. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30412444 DOI: 10.1152/Ajpheart.00587.2018 |
0.445 |
|
| 2018 |
Wang L, Li XX, Chen X, Qin XY, Kardami E, Cheng Y. Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice. Frontiers in Molecular Neuroscience. 11: 377. PMID 30369869 DOI: 10.3389/Fnmol.2018.00377 |
0.328 |
|
| 2018 |
Wang J, Xiang B, Dolinsky VW, Kardami E, Cattini PA. Cardiac Fgf-16 Expression Supports Cardiomyocyte Survival and Increases Resistance to Doxorubicin Cytotoxicity. Dna and Cell Biology. PMID 30230915 DOI: 10.1089/Dna.2018.4362 |
0.454 |
|
| 2018 |
Koleini N, Nickel BE, Edel AL, Fandrich RR, Ravandi A, Kardami E. Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway. Cell and Tissue Research. PMID 30159756 DOI: 10.1007/S00441-018-2905-Z |
0.429 |
|
| 2017 |
Jeyaraman MM, Rabbani R, Copstein L, Sulaiman W, Farshidfar F, Kashani HH, Qadar SMZ, Guan Q, Skidmore B, Kardami E, Ducas J, Mansour S, Zarychanski R, Abou-Setta AM. Autologous Bone Marrow Stem Cell Therapy in Patients With ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. The Canadian Journal of Cardiology. 33: 1611-1623. PMID 29173601 DOI: 10.1016/J.Yjmcc.2017.07.115 |
0.681 |
|
| 2017 |
Koleini N, Nickel BE, Wang J, Roveimiab Z, Fandrich RR, Kirshenbaum LA, Cattini PA, Kardami E. Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway. Oncotarget. 8: 87415-87430. PMID 29152091 DOI: 10.18632/Oncotarget.20558 |
0.381 |
|
| 2016 |
Cheng Y, Li Z, Kardami E, Loh YP. Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons. Neuroscience Letters. PMID 27546824 DOI: 10.1016/J.Neulet.2016.08.031 |
0.38 |
|
| 2014 |
Santiago JJ, McNaughton LJ, Koleini N, Ma X, Bestvater B, Nickel BE, Fandrich RR, Wigle JT, Freed DH, Arora RC, Kardami E. High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. Plos One. 9: e97281. PMID 24827991 DOI: 10.1371/Journal.Pone.0097281 |
0.454 |
|
| 2014 |
Srisakuldee W, Makazan Z, Nickel BE, Zhang F, Thliveris JA, Pasumarthi KB, Kardami E. The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent. Cardiovascular Research. 103: 72-80. PMID 24654232 DOI: 10.1093/Cvr/Cvu066 |
0.46 |
|
| 2013 |
Jeyaraman MM, Fandrich RR, Kardami E. Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor β. Frontiers in Pharmacology. 4: 90. PMID 23882217 DOI: 10.3389/Fphar.2013.00090 |
0.738 |
|
| 2013 |
Lee D, Oka T, Hunter B, Robinson A, Papp S, Nakamura K, Srisakuldee W, Nickel BE, Light PE, Dyck JR, Lopaschuk GD, Kardami E, Opas M, Michalak M. Calreticulin induces dilated cardiomyopathy. Plos One. 8: e56387. PMID 23437120 DOI: 10.1371/Journal.Pone.0056387 |
0.37 |
|
| 2013 |
Sontag DP, Wang J, Kardami E, Cattini PA. FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction. Cardiovascular Toxicology. 13: 244-53. PMID 23430353 DOI: 10.1007/S12012-013-9203-5 |
0.475 |
|
| 2013 |
Wang J, Nachtigal MW, Kardami E, Cattini PA. FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters. Cardiovascular Research. 98: 56-63. PMID 23341575 DOI: 10.1093/Cvr/Cvt011 |
0.413 |
|
| 2012 |
Yeganeh A, Stelmack GL, Fandrich RR, Halayko AJ, Kardami E, Zahradka P. Connexin 43 phosphorylation and degradation are required for adipogenesis. Biochimica Et Biophysica Acta. 1823: 1731-44. PMID 22705883 DOI: 10.1016/J.Bbamcr.2012.06.009 |
0.376 |
|
| 2012 |
Jeyaraman MM, Srisakuldee W, Nickel BE, Kardami E. Connexin43 phosphorylation and cytoprotection in the heart. Biochimica Et Biophysica Acta. 1818: 2009-13. PMID 21763271 DOI: 10.1016/J.Bbamem.2011.06.023 |
0.743 |
|
| 2011 |
Thandapilly SJ, Louis XL, Yang T, Stringer DM, Yu L, Zhang S, Wigle J, Kardami E, Zahradka P, Taylor C, Anderson HD, Netticadan T. Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway. European Journal of Pharmacology. 668: 217-24. PMID 21756902 DOI: 10.1016/J.Ejphar.2011.06.042 |
0.42 |
|
| 2011 |
Jimenez SK, Jassal DS, Kardami E, Cattini PA. Protection by endogenous FGF-2 against isoproterenol-induced cardiac dysfunction is attenuated by cyclosporine A. Molecular and Cellular Biochemistry. 357: 1-8. PMID 21556823 DOI: 10.1007/S11010-011-0868-4 |
0.388 |
|
| 2011 |
Santiago JJ, Ma X, McNaughton LJ, Nickel BE, Bestvater BP, Yu L, Fandrich RR, Netticadan T, Kardami E. Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes. Cardiovascular Research. 89: 139-47. PMID 20696821 DOI: 10.1093/Cvr/Cvq261 |
0.422 |
|
| 2010 |
Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IMC. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts Developmental Dynamics. 239: 1573-1584. PMID 20503355 DOI: 10.1002/Dvdy.22280 |
0.442 |
|
| 2009 |
Jiang ZS, Wen GB, Tang ZH, Srisakuldee W, Fandrich RR, Kardami E. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected]. Canadian Journal of Physiology and Pharmacology. 87: 798-804. PMID 19898562 DOI: 10.1139/Y09-049 |
0.361 |
|
| 2009 |
Srisakuldee W, Jeyaraman MM, Nickel BE, Tanguy S, Jiang ZS, Kardami E. Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state. Cardiovascular Research. 83: 672-81. PMID 19423616 DOI: 10.1093/Cvr/Cvp142 |
0.759 |
|
| 2009 |
Aroutiounova N, Fandrich R, Kardami E, Tappia PS. Prenatal exposure to maternal low protein diet suppresses replicative potential of myocardial cells. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 19: 707-12. PMID 19346111 DOI: 10.1016/J.Numecd.2008.12.014 |
0.306 |
|
| 2008 |
Zhang Y, Kanter EM, Laing JG, Aprhys C, Johns DC, Kardami E, Yamada KA. Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Communication & Adhesion. 15: 289-303. PMID 18923946 DOI: 10.1080/15419060802198736 |
0.41 |
|
| 2008 |
Jimenez SK, Jassal DS, Fang T, Kardami E, Cattini PA. Overexpression of FGF-2 increases cardiac viability after injury assessed by Tissue Doppler imaging Journal of Molecular and Cellular Cardiology. 44: 790. DOI: 10.1016/J.Yjmcc.2008.02.188 |
0.338 |
|
| 2008 |
Srisakuldee W, Makazan Z, Nickel BE, Thliveris JA, Kardami E. Fibroblast growth factor-2 stimulates mitochondrial resistance to injury and phosphorylation of mitochondrial Connexin-43 Journal of Molecular and Cellular Cardiology. 44: 789-790. DOI: 10.1016/J.Yjmcc.2008.02.187 |
0.322 |
|
| 2007 |
Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA. Fibroblast growth factor-2 and cardioprotection. Heart Failure Reviews. 12: 267-77. PMID 17516168 DOI: 10.1007/S10741-007-9027-0 |
0.437 |
|
| 2007 |
Ma X, Dang X, Claus P, Hirst C, Fandrich RR, Jin Y, Grothe C, Kirshenbaum LA, Cattini PA, Kardami E. Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. Journal of Cellular Physiology. 213: 690-8. PMID 17503459 DOI: 10.1002/Jcp.21139 |
0.428 |
|
| 2007 |
Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Progress in Biophysics and Molecular Biology. 94: 245-64. PMID 17462721 DOI: 10.1016/J.Pbiomolbio.2007.03.009 |
0.376 |
|
| 2007 |
Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA, Kardami E. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. Journal of Molecular and Cellular Cardiology. 42: 222-33. PMID 17045289 DOI: 10.1016/J.Yjmcc.2006.09.002 |
0.477 |
|
| 2007 |
Pantos C, Xinaris C, Mourouzis I, Malliopoulou V, Kardami E, Cokkinos DV. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling? Molecular and Cellular Biochemistry. 297: 65-72. PMID 17024559 DOI: 10.1007/S11010-006-9323-3 |
0.396 |
|
| 2007 |
Aroutiounova N, Fandrich R, Kardami E, Tappia PS. WITHDRAWN: Prenatal exposure to maternal low protein is accompanied by altered cell mitotic index in the postnatal heart Journal of Molecular and Cellular Cardiology. 42. DOI: 10.1016/J.Yjmcc.2007.03.894 |
0.317 |
|
| 2007 |
Santiago J, Fandrich R, Kardami E. FGF-2 exported from cardiac fibroblasts may act both systemically and locally depending on isoform composition Journal of Molecular and Cellular Cardiology. 42: S129-S130. DOI: 10.1016/J.Yjmcc.2007.03.368 |
0.365 |
|
| 2006 |
Dang X, Jeyaraman M, Kardami E. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Molecular and Cellular Biochemistry. 289: 201-7. PMID 16718370 DOI: 10.1007/S11010-006-9162-2 |
0.425 |
|
| 2006 |
Srisakuldee W, Nickel BE, Fandrich RR, Jiang ZS, Kardami E. Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites. Cell Communication & Adhesion. 13: 13-9. PMID 16613776 DOI: 10.1080/15419060600631326 |
0.496 |
|
| 2004 |
Detillieux KA, Cattini PA, Kardami E. Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2. Canadian Journal of Physiology and Pharmacology. 82: 1044-52. PMID 15644945 DOI: 10.1139/Y04-126 |
0.371 |
|
| 2004 |
Sheikh F, Hirst CJ, Jin Y, Bock ME, Fandrich RR, Nickel BE, Doble BW, Kardami E, Cattini PA. Inhibition of TGFbeta signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis. Cardiovascular Research. 64: 516-25. PMID 15537505 DOI: 10.1016/J.Cardiores.2004.08.009 |
0.7 |
|
| 2004 |
Kardami E, Jiang ZS, Jimenez SK, Hirst CJ, Sheikh F, Zahradka P, Cattini PA. Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovascular Research. 63: 458-66. PMID 15276471 DOI: 10.1016/J.Cardiores.2004.04.024 |
0.478 |
|
| 2004 |
Jimenez SK, Sheikh F, Jin Y, Detillieux KA, Dhaliwal J, Kardami E, Cattini PA. Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovascular Research. 62: 548-57. PMID 15158147 DOI: 10.1016/J.Cardiores.2004.01.032 |
0.437 |
|
| 2004 |
Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovascular Research. 62: 154-66. PMID 15023562 DOI: 10.1016/J.Cardiores.2004.01.009 |
0.441 |
|
| 2004 |
Doble BW, Dang X, Ping P, Fandrich RR, Nickel BE, Jin Y, Cattini PA, Kardami E. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. Journal of Cell Science. 117: 507-14. PMID 14702389 DOI: 10.1242/Jcs.00889 |
0.688 |
|
| 2003 |
Kardami E, Banerji S, Doble BW, Dang X, Fandrich RR, Jin Y, Cattini PA. PKC-dependent phosphorylation may regulate the ability of connexin43 to inhibit DNA synthesis. Cell Communication & Adhesion. 10: 293-7. PMID 14681031 DOI: 10.1080/Cac.10.4-6.293.297 |
0.693 |
|
| 2003 |
Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Molecular and Cellular Biochemistry. 242: 129-34. PMID 12619875 DOI: 10.1007/978-1-4757-4712-6_17 |
0.441 |
|
| 2003 |
Dang X, Doble BW, Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Molecular and Cellular Biochemistry. 242: 35-8. PMID 12619863 DOI: 10.1007/978-1-4757-4712-6_5 |
0.665 |
|
| 2003 |
Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovascular Research. 57: 8-19. PMID 12504809 DOI: 10.1016/S0008-6363(02)00708-3 |
0.482 |
|
| 2002 |
Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, Cattini PA, Dixon IM, Kardami E. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. American Journal of Physiology. Heart and Circulatory Physiology. 282: H1071-80. PMID 11834506 DOI: 10.1152/Ajpheart.00290.2001 |
0.714 |
|
| 2002 |
Meij JTA, Sheikh F, Jimenez SK, Nickerson PW, Kardami E, Cattini PA. Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent American Journal of Physiology - Heart and Circulatory Physiology. 282: H547-H555. PMID 11788402 DOI: 10.1152/Ajpheart.01019.2000 |
0.432 |
|
| 2002 |
Jimenez S, Sheikh F, Detillieux K, Dhaliwal J, Kardami E, Cattini P. 09 β-adrenergic stimulation increases FGF-2 promoter activity in transgenic mouse hearts Journal of Molecular and Cellular Cardiology. 34: A41. DOI: 10.1016/S0022-2828(02)90217-8 |
0.35 |
|
| 2002 |
Banerji S, Hirst C, Fandrich R, Ping P, Cattini PA, Kardami E. 03 Cardiac myocyte proliferation requires activation of protein kinase C-epsilon Journal of Molecular and Cellular Cardiology. 34: A39. DOI: 10.1016/S0022-2828(02)90211-7 |
0.42 |
|
| 2002 |
Jiang ZS, Soulet F, Bouche G, Dixon IC, Kardami E. 04 Intramyocardial delivery of non-mitogenic FGF-2 to TH eischemic heart is acutely protective Journal of Molecular and Cellular Cardiology. 34. DOI: 10.1016/S0022-2828(02)90180-X |
0.346 |
|
| 2002 |
Jeyaraman M, Fandrich RR, Kardami E. 04 Combined inhibition of PP1 and PP2B phosphatases fully prevents cardiac connexin-43 dephosphorylation during ischemia Journal of Molecular and Cellular Cardiology. 34: A23. DOI: 10.1016/S0022-2828(02)90152-5 |
0.389 |
|
| 2001 |
Doble BW, Ping P, Fandrich RR, Cattini PA, Kardami E. Protein kinase C-epsilon mediates phorbol ester-induced phosphorylation of connexin-43. Cell Communication & Adhesion. 8: 253-6. PMID 12064598 DOI: 10.3109/15419060109080733 |
0.68 |
|
| 2001 |
Sheikh F, Sontag DP, Fandrich RR, Kardami E, Cattini PA. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. American Journal of Physiology. Heart and Circulatory Physiology. 280: H1039-50. PMID 11179045 DOI: 10.1152/Ajpheart.2001.280.3.H1039 |
0.493 |
|
| 2001 |
Sun G, Doble BW, Sun JM, Fandrich RR, Florkiewicz R, Kirshenbaum L, Davie JR, Cattini PA, Kardami E. CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. Journal of Cellular Physiology. 186: 457-67. PMID 11169985 DOI: 10.1002/1097-4652(2000)9999:999<000::Aid-Jcp1044>3.0.Co;2-2 |
0.693 |
|
| 2001 |
Jimenez S, Sheikh F, Meij J, Nickerson P, Kardami E, Cattini P. Increased lesion size and nuclear infiltration are seen in FGF-2 transgenic mouse hearts after ischemic injury in vivo Journal of Molecular and Cellular Cardiology. 33: A54. DOI: 10.1016/S0022-2828(01)90213-5 |
0.33 |
|
| 2001 |
Jiang Z, Soulet F, Bouche G, Dixon IC, Kardami E. Acute cardioprotection by fgf-2 is independent of its mitogenic activity Journal of Molecular and Cellular Cardiology. 33: A53. DOI: 10.1016/S0022-2828(01)90209-3 |
0.316 |
|
| 2001 |
Jeyaraman M, Lukas A, Kardami E. Effect of phosphatase inhibitors on isolated rat cardiomyocyte connexin-43 phosphorylation during ischemia Journal of Molecular and Cellular Cardiology. 33: A53. DOI: 10.1016/S0022-2828(01)90208-1 |
0.342 |
|
| 2001 |
Dang X, Agustiin C, Fandrich RR, Kardami E. Overexpression and localization of truncated connexin 43 in cardiac myocytes Journal of Molecular and Cellular Cardiology. 33: A25. DOI: 10.1016/S0022-2828(01)90099-9 |
0.363 |
|
| 2001 |
Agustin C, Sheikh F, Herlyn M, Cattini PA, Kardami E. Intracrine effects of CUG-initiated FGF-2 on chromatin precede development of apoptotic DNA ladder in cardiomyocytes Journal of Molecular and Cellular Cardiology. 33: A2. DOI: 10.1016/S0022-2828(01)90006-9 |
0.317 |
|
| 2000 |
Fotheringham J, Xu FY, Nemer M, Kardami E, Choy PC, Hatch GM. Lysophosphatidylethanolamine acyltransferase activity is elevated during cardiac cell differentiation Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1485: 1-10. PMID 10802244 DOI: 10.1016/S1388-1981(00)00025-1 |
0.368 |
|
| 2000 |
Xu FY, Kardami E, Nemer M, Choy PC, Hatch GM. Elevation in phosphatidylethanolamine is an early but not essential event for cardiac cell differentiation Experimental Cell Research. 256: 358-364. PMID 10772808 DOI: 10.1006/Excr.2000.4849 |
0.403 |
|
| 2000 |
Doble BW, Ping P, Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circulation Research. 86: 293-301. PMID 10679481 DOI: 10.1161/01.Res.86.3.293 |
0.727 |
|
| 1999 |
Sheikh F, Fandrich RR, Kardami E, Cattini PA. Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovascular Research. 42: 696-705. PMID 10533610 DOI: 10.1016/S0008-6363(99)00008-5 |
0.46 |
|
| 1999 |
Xu FY, Fandrich RR, Nemer M, Kardami E, Hatch GM. The subcellular distribution of protein kinase Calpha, -epsilon, and -zeta isoforms during cardiac cell differentiation. Archives of Biochemistry and Biophysics. 367: 17-25. PMID 10375394 DOI: 10.1006/Abbi.1999.1229 |
0.42 |
|
| 1999 |
Detillieux KA, Meij JTA, Kardami E, Cattini PA. α1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts American Journal of Physiology - Heart and Circulatory Physiology. 276: H826-H833. PMID 10070065 DOI: 10.1152/Ajpheart.1999.276.3.H826 |
0.413 |
|
| 1999 |
Tappia PS, Padua RR, Panagia V, Kardami E. Fibroblast growth factor-2 stimulates phospholipase Cβ in adult cardiomyocytes Biochemistry and Cell Biology. 77: 569-575. DOI: 10.1139/O99-059 |
0.458 |
|
| 1998 |
Kardami E, Doble BW. Cardiomyocyte gap junctions: a target of growth-promoting signaling. Trends in Cardiovascular Medicine. 8: 180-7. PMID 21235931 DOI: 10.1016/S1050-1738(98)00007-3 |
0.733 |
|
| 1998 |
Padua RR, Merle PL, Doble BW, Yu CH, Zahradka P, Pierce GN, Panagia V, Kardami E. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. Journal of Molecular and Cellular Cardiology. 30: 2695-709. PMID 9990540 DOI: 10.1006/Jmcc.1998.0832 |
0.713 |
|
| 1998 |
Eng S, Maddaford TG, Kardami E, Pierce GN. Protection against myocardial ischemic/reperfusion injury by inhibitors of two separate pathways of Na+ entry. Journal of Molecular and Cellular Cardiology. 30: 829-35. PMID 9602432 DOI: 10.1006/Jmcc.1998.0649 |
0.323 |
|
| 1997 |
Sheikh F, Jin Y, Pasumarthi KB, Kardami E, Cattini PA. Expression of fibroblast growth factor receptor-1 in rat heart H9c2 myoblasts increases cell proliferation. Molecular and Cellular Biochemistry. 176: 89-97. PMID 9406149 DOI: 10.1023/A:1006879029333 |
0.43 |
|
| 1997 |
Nagy JI, Li WE, Roy C, Doble BW, Gilchrist JS, Kardami E, Hertzberg EL. Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Experimental Cell Research. 236: 127-36. PMID 9344592 DOI: 10.1006/Excr.1997.3716 |
0.672 |
|
| 1997 |
Liu L, Dai J, Fandrich RR, Kardami E. Cell-cycle dependent anti-FGF-2 staining of chicken cardiac myocytes: Movement from chromosomal to cleavage furrow- and midbody-associated sites Molecular and Cellular Biochemistry. 176: 153-161. DOI: 10.1007/978-1-4615-5765-4_20 |
0.424 |
|
| 1996 |
Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circulation Research. 79: 647-58. PMID 8831488 DOI: 10.1161/01.Res.79.4.647 |
0.738 |
|
| 1996 |
Pasumarthi KB, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circulation Research. 78: 126-36. PMID 8603495 DOI: 10.1161/01.Res.78.1.126 |
0.454 |
|
| 1995 |
Jin Y, Pasumarthi KB, Bock ME, Lytras A, Kardami E, Cattini PA. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. Journal of Molecular and Cellular Cardiology. 26: 1449-59. PMID 7897669 DOI: 10.1006/Jmcc.1994.1164 |
0.398 |
|
| 1995 |
Doble BW, Kardami E. Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Molecular and Cellular Biochemistry. 143: 81-7. PMID 7776963 DOI: 10.1007/Bf00925930 |
0.712 |
|
| 1995 |
Liu L, Pasumarthi KB, Padua RR, Massaeli H, Fandrich RR, Pierce GN, Cattini PA, Kardami E. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. The American Journal of Physiology. 268: H1927-38. PMID 7771542 DOI: 10.1152/Ajpheart.1995.268.5.H1927 |
0.4 |
|
| 1995 |
Jin Y, Pasumarthi KB, Bock ME, Chen Y, Kardami E, Cattini PA. Effect of "enhancer" sequences on ventricular myosin light chain-2 promoter activity in heart muscle and nonmuscle cells. Biochemical and Biophysical Research Communications. 210: 260-6. PMID 7755599 DOI: 10.1006/Bbrc.1995.1655 |
0.393 |
|
| 1995 |
Pasumarthi KB, Jin Y, Bock ME, Lytras A, Kardami E, Cattini PA. Characterization of fibroblast growth factor receptor 1 RNA expression in the embryonic mouse heart. Annals of the New York Academy of Sciences. 752: 406-16. PMID 7755284 DOI: 10.1111/J.1749-6632.1995.Tb17448.X |
0.374 |
|
| 1995 |
Kardami E, Liu L, Pasumarthi SK, Doble BW, Cattini PA. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Annals of the New York Academy of Sciences. 752: 353-69. PMID 7755280 DOI: 10.1111/J.1749-6632.1995.Tb17444.X |
0.693 |
|
| 1995 |
Padua RR, Sethi R, Dhalla NS, Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Molecular and Cellular Biochemistry. 143: 129-35. PMID 7596347 DOI: 10.1007/Bf01816946 |
0.421 |
|
| 1994 |
Pasumarthi KB, Doble BW, Kardami E, Cattini PA. Over-expression of CUG- or AUG-initiated forms of basic fibroblast growth factor in cardiac myocytes results in similar effects on mitosis and protein synthesis but distinct nuclear morphologies. Journal of Molecular and Cellular Cardiology. 26: 1045-60. PMID 7799445 DOI: 10.1006/Jmcc.1994.1125 |
0.701 |
|
| 1993 |
Liu L, Doble BW, Kardami E. Perinatal phenotype and hypothyroidism are associated with elevated levels of 21.5- to 22-kDa basic fibroblast growth factor in cardiac ventricles. Developmental Biology. 157: 507-16. PMID 8500657 DOI: 10.1006/Dbio.1993.1153 |
0.702 |
|
| 1993 |
Padua RR, Kardami E. Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury. Growth Factors (Chur, Switzerland). 8: 291-306. PMID 8347345 DOI: 10.3109/08977199308991574 |
0.45 |
|
| 1993 |
Kardami E, Padua RR, Pasumarthi KBS, Liu L, Doble BW, Davey SE, Cattini PA. Basic fibroblast growth factor in cardiac myocytes: expression and effects Developments in Cardiovascular Medicine. 147: 55-75. DOI: 10.1007/978-1-4615-3098-5_5 |
0.717 |
|
| 1992 |
Kardami E, Pearson TW, Beecroft RP, Fandrich RR. Identification of basic fibroblast growth factor-like proteins in African trypanosomes and Leishmania Molecular and Biochemical Parasitology. 51: 171-181. PMID 1574077 DOI: 10.1016/0166-6851(92)90067-T |
0.343 |
|
| 1991 |
Kardami E. A potential new role for bFGF in host-parasite interactions. Growth Factors (Chur, Switzerland). 4: 61-8. PMID 2128183 DOI: 10.3109/08977199009011011 |
0.335 |
|
| 1991 |
Cattini PA, Nickel B, Bock M, Kardami E. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells: a possible role for bFGF in placental cell development. Placenta. 12: 341-52. PMID 1946244 DOI: 10.1016/0143-4004(91)90342-D |
0.381 |
|
| 1991 |
Kardami E, Stoski RM, Doble BW, Yamamoto T, Hertzberg EL, Nagy JI. Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. The Journal of Biological Chemistry. 266: 19551-7. PMID 1918064 |
0.677 |
|
| 1991 |
Anderson JE, Liu L, Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Developmental Biology. 147: 96-109. PMID 1879618 DOI: 10.1016/S0012-1606(05)80010-7 |
0.331 |
|
| 1991 |
Kardami E, Liu L, Doble BW. Basic fibroblast growth factor in cultured cardiac myocytes. Annals of the New York Academy of Sciences. 638: 244-55. PMID 1785804 DOI: 10.1111/J.1749-6632.1991.Tb49035.X |
0.706 |
|
| 1991 |
KARDAMI E. Anti-basic fibroblast growth factor labelling of cardiac myocytes during mitosis in vitro Journal of Molecular and Cellular Cardiology. 23: S54. DOI: 10.1016/0022-2828(91)91485-A |
0.315 |
|
| 1990 |
Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Molecular and Cellular Biochemistry. 92: 129-35. PMID 2308582 DOI: 10.1007/Bf00218130 |
0.457 |
|
| 1990 |
Doble BW, Fandrich RR, Liu L, Padua RR, Kardami E. Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases. Biochemical and Biophysical Research Communications. 173: 1116-22. PMID 2268315 DOI: 10.1016/S0006-291X(05)80901-5 |
0.651 |
|
| 1990 |
Kardami E, Murphy LJ, Liu L, Padua RR, Fandrich RR. Characterization of two preparations of antibodies to basic fibroblast growth factor which exhibit distinct patterns of immunolocalization Growth Factors. 4: 69-80. PMID 1707636 DOI: 10.3109/08977199009011012 |
0.327 |
|
| 1989 |
Kardami E, Fandrich RR. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. The Journal of Cell Biology. 109: 1865-75. PMID 2677031 DOI: 10.1083/Jcb.109.4.1865 |
0.39 |
|
| 1988 |
Kardami E, Spector D, Strohman RC. Heparin inhibits skeletal muscle growth in vitro Developmental Biology. 126: 19-28. PMID 3342932 DOI: 10.1016/0012-1606(88)90234-5 |
0.36 |
|
| 1985 |
Kardami E, Spector D, Strohman RC. Selected muscle and nerve extracts contain an activity which stimulates myoblast proliferation and which is distinct from transferrin Developmental Biology. 112: 353-358. PMID 3908194 DOI: 10.1016/0012-1606(85)90406-3 |
0.325 |
|
| 1985 |
Kardami E, Spector D, Strohman RC. Myogenic growth factor present in skeletal muscle is purified by heparin-affinity chromatography Proceedings of the National Academy of Sciences of the United States of America. 82: 8044-8047. PMID 3865214 DOI: 10.1073/Pnas.82.23.8044 |
0.343 |
|
| Show low-probability matches. |